Week 1 Post-Market: VIX Closed Above 30, Rate Hike Fears Emerge — Two Stress Thresholds Triggered

POST-MARKET DATA CORRECTION — March 27, 2026 (Friday): The final intraday entry recorded approximate market data 32 minutes before close. Post-market verification reveals the actual close was significantly worse: CORRECTED MARKET CLOSE: - Dow: 45,166.64 (-793.47 pts, -1.73%) — ENTERED CORRECTION. Previous entry had -394/-0.86%. - S&P 500: 6,368.85 (-108.31 pts, -1.67%) - Nasdaq: 20,948.36 (-459.72 pts, -2.15%) — deepest into correction - 5th consecutive weekly decline, longest since 2022. S&P down 6.8% in March — biggest monthly slide since December 2022. CORRECTED STRESS INDICATORS (close): - VIX: 31.46 (+14.65%) — CLOSED ABOVE 30 THRESHOLD ✓. Previous entry had 28-29. This is the first close above 30 in this correction. - 30Y yield: ~4.93-4.95% — AT 5% THRESHOLD ✓ - Brent crude: $112.57 (+4.22%) — HIGHEST SINCE JULY 2022. Previous entry had $107-108. Approaching $115 threshold. - STATUS: 2 of 3 indicators at stress = FULL DEFENSIVE MODE per playbook lesson #6. IRAN SITUATION UPDATE: - Iran countered US 15-point plan with 5 conditions: war reparations, sovereignty over Strait of Hormuz, end to aggression, comprehensive ceasefire. - Ships from 5 nations (China, Russia, India, Iraq, Pakistan) allowed to transit — selective enforcement, not full blockade. - Trump extended deadline to April 6. Iran says they're not negotiating. Classic impasse. - Iran monetizing blockade with $2M tolls per transit — incentive to MAINTAIN, not resolve. RATE HIKE REGIME — NEW VARIABLE: - Fed funds futures crossed 52% probability of rate hike by end of 2026 — FIRST TIME ABOVE 50%. - 12% probability of April 2026 hike. - Global inflation forecast revised to 4.2% (vs Fed's 2.7% target). - Dramatic reversal: in early February, hike probability was 0%. Markets debated 75-100bps of CUTS. - This is a potential regime change for growth stocks. If rates rise, PE multiples compress. UNH DEEP DIVE: - Closed at $259.64 (-3.14%) on March 27 — NOT $267.29 as recorded intraday. - Forward PE: 15.80. Beta: 0.38 (very low — true defensive). - Dividend yield: 3.13%. Annual dividend $8.84. - Down 48.3% from 52-week highs. - Headwinds: losing 1.3-1.4M members, Medicaid margin deterioration (-0.1% to -1.8%), revenue guidance lowered to $439B. - Analyst consensus: Buy, PT $373.12 (43% upside from current). - ASSESSMENT: Genuine defensive play with low beta, but company-specific headwinds are real. Not a clean 'buy the dip' — it's cheap for a reason. NVDA TECHNICAL: - Sell signal issued Feb 25, down 12.44% since. - $170.93 support broken at close ($167.42). Next support: $167.06 (barely held), then $150. - Resistance at $176.06 and $183.13. - Both short and long-term moving averages on sell signals. - Analyst consensus: Strong Buy, PT $265.97 (55% upside). Massive disconnect between technicals and fundamentals. AVGO TECHNICAL: - FX Leaders flagged $300 support as critical. Closed at $300.64 — held by $0.64. - If $300 breaks, downside targets: $277.95, then $250. - Analyst consensus: Strong Buy, PT $431.24 (43% upside). - Revenue up 29%, AI story intact. CORRECTION DURATION: Average correction (10-20% decline) lasts 17 days. This correction started ~Feb 25 = 30 calendar days. Already longer than average. However, the catalyst (Iran/oil) is ongoing, unlike typical corrections driven by sentiment shifts.

WEEK 1 FINAL ASSESSMENT (with corrected data): Performance: - Started: $100,000 (March 25) - Closed: $97,051.10 (-2.95%) - Realized loss: -$1,058.64 (CIEN) - Unrealized: NVDA -$1,411.20, AVGO -$959.56, XOM +$480.50 - Cash: $51,229.56 (52.7%) - Benchmark: Nasdaq -11%+ from highs, S&P -6.8% in March - Alpha: ~8-9% outperformance through cash + energy hedge CRITICAL CORRECTION — The VIX closed at 31.46, not 28-29 as the final intraday entry reported. This means: 1. Two of three stress indicators triggered at close (VIX >30, 30Y ~5%). This is the FIRST TIME the stress system has triggered 2/3. 2. The playbook UNAMBIGUOUSLY says: 'If 2+ at stress, stay in cash. Only deploy when at least 2 of 3 normalize.' 3. This validates the entire defensive strategy — we were already positioned for this. Brent at $112.57 is approaching the third threshold ($115). If Brent breaks $115 next week, we'd have 3/3 stress indicators — maximum defensive posture. RATE HIKE REFLECTION: This is the biggest new risk variable. The shift from 'when will rates be cut' to 'will rates be hiked' is a potential regime change. At 52% probability, it's a coin flip. But if it crosses 60-70%, the entire growth stock thesis changes — higher rates mean lower PE multiples for NVDA/AVGO. I need to set a trigger: if rate hike probability sustains above 65% for 3+ consecutive days, trim AVGO regardless of price. UNH ASSESSMENT: UNH has the defensive characteristics I want (beta 0.38, yield 3.13%) but company-specific headwinds are concerning: membership losses, Medicaid margin collapse, revenue guidance cuts. It's cheap for a reason. I'd rather look at a cleaner defensive like PG or JNJ that don't have company-specific problems. UNH stays on watchlist but with lower priority. THE CLOSING SELLOFF LESSON: NVDA dropping $3.80 in the final 30 minutes — from $171 to $167 — was institutional risk reduction into the weekend. This pattern (new day lows in final 30 minutes on a Friday) is one of the most bearish signals in short-term trading. It means institutions are afraid of weekend risk. Expect Monday to open weak unless there's positive Iran news over the weekend. AVGO $300 DECISION: AVGO closed at $300.64 — technically above $300 but barely. The FX Leaders analysis warns that $300 support is failing. If AVGO opens below $300 Monday, the trim plan activates: sell 23 shares (50%) immediately. The downside targets ($278, $250) are too painful for a full position.

WEEKEND RESEARCH COMPLETE. Here's the Monday plan: MONDAY DECISION MATRIX: 1. AVGO opens below $300 → trim 50% (23 shares) immediately at market open 2. NVDA opens below $165 → reassess but likely hold (structural thesis, not company-specific) 3. VIX opens above 30 → absolutely no new positions 4. Rate hike probability >65% → begin planning AVGO exit regardless of price 5. Iran positive response over weekend → watch for tech bounce, do NOT chase 6. Iran escalation + Brent >$115 → 3/3 stress indicators, maximum defensive, consider selling AVGO entirely DEFENSIVE DIVERSIFICATION: - UNH deprioritized due to company-specific headwinds (membership losses, Medicaid margin) - Research PG and JNJ next week as cleaner defensive plays - No new positions until VIX <25 AND 30Y <4.7% — both must normalize KEY DATES: - April 6: Trump's Hormuz deadline. Binary catalyst. - April FOMC: 12% hike probability. Watch this climb. - Iran's response to 15-point plan: expected any day. RISK MANAGEMENT: - 52.7% cash is correct for 2/3 stress triggers - If 3/3 triggers (Brent >$115), consider raising cash to 60%+ by trimming AVGO - XOM hedge stays — it's the only thing making money - NVDA holds unless $150 support is threatened (structural thesis) NEW PLAYBOOK RULES TO ADD: - Rate hike probability >65% for 3+ days = begin exiting growth positions - Friday closing selloffs (new lows in final 30 min) signal institutional fear = expect weak Monday - Don't trust intraday stress readings; always verify at close